Identification of tumor antigens and anoikis-based molecular subtypes in the hepatocellular carcinoma immune microenvironment: implications for mRNA vaccine development and precision treatment

Abstract Hepatocellular carcinoma (HCC) represents a formidable malignancy with a high lethality. Nonetheless, the development of vaccine and the establishment of prognostic models for precise and personalized treatment of HCC still encounter big challenges. Thus, the aim of this study was to develo...

Full description

Bibliographic Details
Main Authors: Zhiyuan Zheng, Hantao Yang, Yang Shi, Feng Zhou, Lingxiao Liu, Zhiping Yan, Xiaolin Wang
Format: Article
Language:English
Published: SpringerOpen 2023-08-01
Series:Journal of Big Data
Subjects:
Online Access:https://doi.org/10.1186/s40537-023-00803-7
_version_ 1797559129867288576
author Zhiyuan Zheng
Hantao Yang
Yang Shi
Feng Zhou
Lingxiao Liu
Zhiping Yan
Xiaolin Wang
author_facet Zhiyuan Zheng
Hantao Yang
Yang Shi
Feng Zhou
Lingxiao Liu
Zhiping Yan
Xiaolin Wang
author_sort Zhiyuan Zheng
collection DOAJ
description Abstract Hepatocellular carcinoma (HCC) represents a formidable malignancy with a high lethality. Nonetheless, the development of vaccine and the establishment of prognostic models for precise and personalized treatment of HCC still encounter big challenges. Thus, the aim of this study was to develop HCC vaccines and explore anoikis-based prognostic models based on RNA sequencing data in GEO datasets (GSE10143, GSE76427) and the TCGA-LIHC cohort. Potential HCC antigens were identified using GEPIA2, cBioPortal, and TIMER2. Anoikis-related subtypes and gene clusters were defined by consensus clustering of 566 liver cancer samples based on 28 anoikis regulators, and we further analyzed their relationship with the immune microenvironment of HCC. A predictive model based on anoikis-related long noncoding RNAs (lncRNAs) was developed to accurately predict HCC prognosis. Seven overexpressed genes associated with HCC prognosis and tumor-infiltrating antigen-presenting cells were identified as potential tumor antigens for the development of HCC mRNA vaccines. Two subtypes based on anoikis-related genes (ARGs) and two gene clusters with different characteristics were identified and validated in defined cohorts. The tumor immune microenvironment between the two subtypes showed different cell infiltration and molecular characteristics. Furthermore, a prognostic score based on seven lncRNAs identified by LASSO regression was constructed, with the low-risk group having favorable prognosis, a “hot” immune microenvironment, and better response to immunotherapy. CCNB1, CDK1, DNASE1L3, KPNA2, PRC1, PTTG, and UBE2S were first identified as promising tumor antigens for mRNA vaccine development in HCC. Besides, we innovatively propose anoikis-based molecular subtypes, which not only enable personalized prognostic stratification of HCC patients but also provide a blueprint for identifying optimal candidates for tumor vaccines, enhancing immunotherapeutic strategies.
first_indexed 2024-03-10T17:41:03Z
format Article
id doaj.art-ae72d9a492544813a33fbe984631c341
institution Directory Open Access Journal
issn 2196-1115
language English
last_indexed 2024-03-10T17:41:03Z
publishDate 2023-08-01
publisher SpringerOpen
record_format Article
series Journal of Big Data
spelling doaj.art-ae72d9a492544813a33fbe984631c3412023-11-20T09:42:37ZengSpringerOpenJournal of Big Data2196-11152023-08-0110113210.1186/s40537-023-00803-7Identification of tumor antigens and anoikis-based molecular subtypes in the hepatocellular carcinoma immune microenvironment: implications for mRNA vaccine development and precision treatmentZhiyuan Zheng0Hantao Yang1Yang Shi2Feng Zhou3Lingxiao Liu4Zhiping Yan5Xiaolin Wang6Department of Interventional Radiology, Zhongshan Hospital Fudan University and Shanghai Institute of Medical Imaging, Fudan UniversityDepartment of Neurosurgery, Zhongshan Hospital Fudan UniversityFaculty of Medicine, Institute for Experimental Molecular Imaging, Uniklinik RWTH Aachen and Helmholtz Institute for Biomedical Engineering, RWTH Aachen UniversityDepartment of Neurosurgery, Baoji Central HospitalDepartment of Interventional Radiology, Zhongshan Hospital Fudan University and Shanghai Institute of Medical Imaging, Fudan UniversityDepartment of Interventional Radiology, Zhongshan Hospital Fudan University and Shanghai Institute of Medical Imaging, Fudan UniversityDepartment of Interventional Radiology, Zhongshan Hospital Fudan University and Shanghai Institute of Medical Imaging, Fudan UniversityAbstract Hepatocellular carcinoma (HCC) represents a formidable malignancy with a high lethality. Nonetheless, the development of vaccine and the establishment of prognostic models for precise and personalized treatment of HCC still encounter big challenges. Thus, the aim of this study was to develop HCC vaccines and explore anoikis-based prognostic models based on RNA sequencing data in GEO datasets (GSE10143, GSE76427) and the TCGA-LIHC cohort. Potential HCC antigens were identified using GEPIA2, cBioPortal, and TIMER2. Anoikis-related subtypes and gene clusters were defined by consensus clustering of 566 liver cancer samples based on 28 anoikis regulators, and we further analyzed their relationship with the immune microenvironment of HCC. A predictive model based on anoikis-related long noncoding RNAs (lncRNAs) was developed to accurately predict HCC prognosis. Seven overexpressed genes associated with HCC prognosis and tumor-infiltrating antigen-presenting cells were identified as potential tumor antigens for the development of HCC mRNA vaccines. Two subtypes based on anoikis-related genes (ARGs) and two gene clusters with different characteristics were identified and validated in defined cohorts. The tumor immune microenvironment between the two subtypes showed different cell infiltration and molecular characteristics. Furthermore, a prognostic score based on seven lncRNAs identified by LASSO regression was constructed, with the low-risk group having favorable prognosis, a “hot” immune microenvironment, and better response to immunotherapy. CCNB1, CDK1, DNASE1L3, KPNA2, PRC1, PTTG, and UBE2S were first identified as promising tumor antigens for mRNA vaccine development in HCC. Besides, we innovatively propose anoikis-based molecular subtypes, which not only enable personalized prognostic stratification of HCC patients but also provide a blueprint for identifying optimal candidates for tumor vaccines, enhancing immunotherapeutic strategies.https://doi.org/10.1186/s40537-023-00803-7HCCAnoikisPrognosisSubtypeTCGAGEO
spellingShingle Zhiyuan Zheng
Hantao Yang
Yang Shi
Feng Zhou
Lingxiao Liu
Zhiping Yan
Xiaolin Wang
Identification of tumor antigens and anoikis-based molecular subtypes in the hepatocellular carcinoma immune microenvironment: implications for mRNA vaccine development and precision treatment
Journal of Big Data
HCC
Anoikis
Prognosis
Subtype
TCGA
GEO
title Identification of tumor antigens and anoikis-based molecular subtypes in the hepatocellular carcinoma immune microenvironment: implications for mRNA vaccine development and precision treatment
title_full Identification of tumor antigens and anoikis-based molecular subtypes in the hepatocellular carcinoma immune microenvironment: implications for mRNA vaccine development and precision treatment
title_fullStr Identification of tumor antigens and anoikis-based molecular subtypes in the hepatocellular carcinoma immune microenvironment: implications for mRNA vaccine development and precision treatment
title_full_unstemmed Identification of tumor antigens and anoikis-based molecular subtypes in the hepatocellular carcinoma immune microenvironment: implications for mRNA vaccine development and precision treatment
title_short Identification of tumor antigens and anoikis-based molecular subtypes in the hepatocellular carcinoma immune microenvironment: implications for mRNA vaccine development and precision treatment
title_sort identification of tumor antigens and anoikis based molecular subtypes in the hepatocellular carcinoma immune microenvironment implications for mrna vaccine development and precision treatment
topic HCC
Anoikis
Prognosis
Subtype
TCGA
GEO
url https://doi.org/10.1186/s40537-023-00803-7
work_keys_str_mv AT zhiyuanzheng identificationoftumorantigensandanoikisbasedmolecularsubtypesinthehepatocellularcarcinomaimmunemicroenvironmentimplicationsformrnavaccinedevelopmentandprecisiontreatment
AT hantaoyang identificationoftumorantigensandanoikisbasedmolecularsubtypesinthehepatocellularcarcinomaimmunemicroenvironmentimplicationsformrnavaccinedevelopmentandprecisiontreatment
AT yangshi identificationoftumorantigensandanoikisbasedmolecularsubtypesinthehepatocellularcarcinomaimmunemicroenvironmentimplicationsformrnavaccinedevelopmentandprecisiontreatment
AT fengzhou identificationoftumorantigensandanoikisbasedmolecularsubtypesinthehepatocellularcarcinomaimmunemicroenvironmentimplicationsformrnavaccinedevelopmentandprecisiontreatment
AT lingxiaoliu identificationoftumorantigensandanoikisbasedmolecularsubtypesinthehepatocellularcarcinomaimmunemicroenvironmentimplicationsformrnavaccinedevelopmentandprecisiontreatment
AT zhipingyan identificationoftumorantigensandanoikisbasedmolecularsubtypesinthehepatocellularcarcinomaimmunemicroenvironmentimplicationsformrnavaccinedevelopmentandprecisiontreatment
AT xiaolinwang identificationoftumorantigensandanoikisbasedmolecularsubtypesinthehepatocellularcarcinomaimmunemicroenvironmentimplicationsformrnavaccinedevelopmentandprecisiontreatment